Apogenix
PrivateLast Round
Liquidation
Dec 31, 2025
Total Funding Raised
$115.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Apogenix is a biopharmaceutical company that develops novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apogenix Comparables
Compare Apogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CANbridge Pharma | 74% | |
| AbbVie | 70% | |
| Anaveon | 61% |
Apogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Liquidation | Dec 31, 2025 | ||||
| Grant | Dec 9, 2021 | ||||
| Grant | Feb 16, 2016 | ||||
| Grant | Jan 3, 2012 | ||||
| Grant | Jul 29, 2009 | ||||
Grant | Sep 19, 2008 |
Apogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dievini Hopp BioTech holding | Seed, Corporate Funding, Series B, Grant |
| Bundesregierung | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2025
Company has raised a liquidation round.
- Dec 9, 2021
$29.15M round led by dievini Hopp BioTech holding.
Apogenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Apogenix's valuation, stock price, and market status.
Is Apogenix a public or private company?
Apogenix is a private company.
What is the current stock price of Apogenix?
Apogenix is a private company with no public stock price. No recent secondary market data is available.
How much is Apogenix worth (valuation)?
Valuation information for Apogenix is not publicly available.
Can I buy Apogenix stock?
Apogenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Apogenix's last funding round?
Apogenix's most recent funding round was VC Round on December 9, 2021.
Who are the main investors in Apogenix?
Investor information for Apogenix is not publicly disclosed.
Will Apogenix IPO soon?
No public IPO plans have been announced for Apogenix.
How can I track Apogenix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apogenix's secondary market activity and sign up for updates.